Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Nutex Health (NUTX) Short-Term Debt repayments (2016 - 2025)

Nutex Health's Short-Term Debt repayments history spans 9 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Short-Term Debt repayments rose 375.42% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $7.9 million, up 277.92%, while the annual FY2025 figure was $7.9 million, 277.92% up from the prior year.
  • Short-Term Debt repayments for Q4 2025 was $4.6 million at Nutex Health, up from $3.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $4.6 million in Q4 2025 and bottomed at -$1000.0 in Q2 2024.
  • The 5-year median for Short-Term Debt repayments is $50095.0 (2021), against an average of $773838.4.
  • The largest annual shift saw Short-Term Debt repayments soared 335564.34% in 2024 before it crashed 50.92% in 2025.
  • A 5-year view of Short-Term Debt repayments shows it stood at $1463.0 in 2021, then soared by 1741.97% to $26948.0 in 2022, then plummeted by 98.94% to $286.0 in 2023, then skyrocketed by 335564.34% to $960000.0 in 2024, then surged by 375.42% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Short-Term Debt repayments are $4.6 million (Q4 2025), $3.0 million (Q3 2025), and $9000.0 (Q2 2025).